Want to see BICX full AI Analyst Report?
BioCorRx (BICX) Financial Statements
BioCorRx Financial Overview
BioCorRx's market cap is currently $5.98M. The company's EPS TTM is $-0.13; its P/E ratio is -1.58; BioCorRx has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 797.24K | $ 7.67K | $ 89.16K | $ 213.84K | $ 48.27K |
| Gross Profit | $ 691.38K | $ 6.00K | $ 53.17K | $ 198.56K | $ 42.39K |
| Operating Income | $ -4.83M | $ -5.12M | $ -3.79M | $ -2.91M | $ -4.53M |
| EBITDA | $ -2.60M | $ -3.59M | $ -2.68M | $ -3.15M | $ -4.48M |
| Net Income | $ -3.44M | $ -5.11M | $ -3.77M | $ -4.37M | $ -5.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 139.36K | $ 88.03K | $ 65.22K | $ 68.61K | $ 85.84K |
| Total Assets | $ 2.15M | $ 385.94K | $ 388.89K | $ 766.59K | $ 819.98K |
| Total Debt | $ 2.13M | $ 7.11M | $ 1.81M | $ 1.68M | $ 1.77M |
| Net Debt | $ 1.99M | $ 7.02M | $ 1.75M | $ 1.61M | $ 1.69M |
| Total Liabilities | $ 13.67M | $ 12.74M | $ 10.34M | $ 8.97M | $ 7.78M |
| Stockholders' Equity | $ -11.22M | $ -12.12M | $ -9.82M | $ -8.08M | $ -6.84M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.30M | $ -1.10M | $ -1.85M | $ -2.04M | $ -3.59M |
| Operating Cash Flow | $ -2.30M | $ -1.10M | $ -1.85M | $ -2.04M | $ -3.54M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -50.00K |
| Financing Cash Flow | $ 2.35M | $ 1.12M | $ 1.85M | $ 2.02M | $ 3.08M |
Currency in USD
